Brief: Herantis Pharma H2 Loss At EUR 3.4 Mln
March 5 (Reuters) - Herantis Pharma Oyj HRTIS.HE: H2 PROFIT EUR -3.42 MILLION H2 OTHER OPERATING INCOME EUR 43,000 Further company coverage: HRTIS.HE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))